CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (73,988)	$ (52)
Adjustments to reconcile net loss to net cash provided by operating activities:
Gain on divestiture	0	(1,459)
Depreciation and amortization	42,349	36,682
Impairment of goodwill and long-lived assets	61,109	0
Deferred income taxes	(6,911)	(12,849)
Employee benefit plans settlement expenses	385	25,701
Stock-based compensation	2,508	2,073
Other, net	47	0
Loss (gain) on disposition of property, plant and equipment	164	(43)
Income from equity method investment	(24)	(120)
Changes in operating assets and liabilities:
Accounts receivable	(8,288)	10,528
Contract assets	1,269	(4,330)
Inventories	10,117	(6,206)
Accounts payable	28,391	13,427
Accrued payroll and other compensation	7,192	4,935
Accrued taxes	4,558	1,810
Other, net	5,735	(7,133)
Net cash provided by operating activities	74,613	62,964
Cash flows from investing activities:
Capital expenditures	(20,540)	(27,236)
Collections of finance receivables	4,257	0
Proceeds from divestiture	0	2,298
Proceeds from the sale of property, plant and equipment	14	297
Business acquisitions, net of cash acquired	0	869
Net cash used for investing activities	(16,269)	(23,772)
Cash flows from financing activities:
Proceeds from borrowings	20,000	0
Debt repayments	(9,500)	(38,185)
Proceeds from servicing receivables	207	0
Common stock issued	32	5
Common stock repurchased	(31)	(50)
Net cash provided by (used for) financing activities	10,708	(38,230)
Effect of exchange rate changes on cash	1,660	(1,280)
Increase (decrease) in cash and cash equivalents	70,712	(318)
Cash and cash equivalents at beginning of period	51,331	49,237
Cash and cash equivalents at end of period	$ 122,043	$ 48,919